CinRx Pharma is a multi-asset biotech company focusing on advancing novel therapeutics that address large unmet medical needs. CinRx acquires compounds from large pharma, biotech companies, academia, or by repurposing existing formulations that are available in the generic space. The compounds are developed using CinRx's formulation, pre-clinical, and CMC expertise in conjunction with Medpace, Inc., a global CRO. CinRx is led by Jon Isaacsohn, MD, former CMO of Teva Pharmaceutical's branded division, Catherine Soldano, former VP at Teva's New Therapeutic Entity (NTE) group, and Piyush Patel, PhD, former Senior Director of Product Development at Teva Pharmaceutical and Director of Formulation Development at Cephalon.